Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Is there a clinical difference between influenza A and B virus infections in hospitalized patients? : Results after routine polymerase chain reaction point-of-care testing in the emergency room from 2017/2018.

Karolyi M, Pawelka E, Daller S, Kaczmarek C, Laferl H, Niculescu I, Schrader B, Stütz C, Zoufaly A, Wenisch C.

Wien Klin Wochenschr. 2019 Aug;131(15-16):362-368. doi: 10.1007/s00508-019-1519-0. Epub 2019 Jun 18.

2.

Influenza virus infection: an approach to identify predictors for in-hospital and 90-day mortality from patients in Vienna during the season 2017/18.

Pawelka E, Karolyi M, Daller S, Kaczmarek C, Laferl H, Niculescu I, Schrader B, Stütz C, Zoufaly A, Wenisch C.

Infection. 2020 Feb;48(1):51-56. doi: 10.1007/s15010-019-01335-0. Epub 2019 Jun 15.

PMID:
31203513
3.

Increase in human West Nile and Usutu virus infections, Austria, 2018.

Aberle SW, Kolodziejek J, Jungbauer C, Stiasny K, Aberle JH, Zoufaly A, Hourfar MK, Weidner L, Nowotny N.

Euro Surveill. 2018 Oct;23(43). doi: 10.2807/1560-7917.ES.2018.23.43.1800545.

4.

Tuberculosis in people newly diagnosed with HIV at a large HIV care and treatment center in Northwest Cameroon: Burden, comparative screening and diagnostic yields, and patient outcomes.

Mbu ET, Sauter F, Zoufaly A, Bronsvoort BMC, Morgan KL, Noeske J, Abena JF, Sander MS.

PLoS One. 2018 Jun 26;13(6):e0199634. doi: 10.1371/journal.pone.0199634. eCollection 2018.

5.

Incidence and risk factors for relapses in HIV-associated non-Hodgkin lymphoma as observed in the German HIV-related lymphoma cohort study.

Schommers P, Gillor D, Hentrich M, Wyen C, Wolf T, Oette M, Zoufaly A, Wasmuth JC, Bogner JR, Müller M, Esser S, Schleicher A, Jensen B, Stoehr A, Behrens G, Schultze A, Siehl J, Thoden J, Taylor N, Hoffmann C.

Haematologica. 2018 May;103(5):857-864. doi: 10.3324/haematol.2017.180893. Epub 2018 Feb 8.

6.

Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013.

Zoufaly A, Kraft C, Schmidbauer C, Puchhammer-Stoeckl E.

Infection. 2017 Apr;45(2):165-170. doi: 10.1007/s15010-016-0936-5. Epub 2016 Aug 16.

PMID:
27530391
7.

Necrotizing fasciitis due to Vibrio cholerae non-O1/non-O139 after exposure to Austrian bathing sites.

Hirk S, Huhulescu S, Allerberger F, Lepuschitz S, Rehak S, Weil S, Gschwandtner E, Hermann M, Neuhold S, Zoufaly A, Indra A.

Wien Klin Wochenschr. 2016 Feb;128(3-4):141-5. doi: 10.1007/s00508-015-0944-y. Epub 2016 Jan 29.

8.

Virological failure after 1 year of first-line ART is not associated with HIV minority drug resistance in rural Cameroon .

Zoufaly A, Jochum J, Hammerl R, Nassimi N, Raymond Y, Burchard GD, Schmiedel S, Drexler JF, Campbell NK, Taka N, Awasom C, Metzner KJ, van Lunzen J, Feldt T.

J Antimicrob Chemother. 2015 Mar;70(3):922-5. doi: 10.1093/jac/dku470. Epub 2014 Nov 26.

9.

Survival of AIDS-related diffuse large B-cell lymphoma, Burkitt lymphoma, and plasmablastic lymphoma in the German HIV Lymphoma Cohort.

Schommers P, Hentrich M, Hoffmann C, Gillor D, Zoufaly A, Jensen B, Bogner JR, Thoden J, Wasmuth JC, Wolf T, Oette M, Müller M, Esser S, Vehreschild JJ, Fätkenheuer G, Wyen C.

Br J Haematol. 2015 Mar;168(6):806-10. doi: 10.1111/bjh.13221. Epub 2014 Nov 17.

PMID:
25403997
10.

Determinants of HIV-1 drug resistance in treatment-naïve patients and its clinical implications in an antiretroviral treatment program in Cameroon.

Zoufaly A, Jochum J, Hammerl R, Nassimi N, Raymond Y, Burchard GD, Schmiedel S, Drexler JF, Kay CN, Taka N, Awasom C, Metzner K, Jan vL, Feldt T.

J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19615. doi: 10.7448/IAS.17.4.19615. eCollection 2014.

11.

Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals.

Zoufaly A, Kiepe JG, Hertling S, Hüfner A, Degen O, Feldt T, Schmiedel S, Kurowski M, van Lunzen J.

HIV Med. 2014 Sep;15(8):449-57. doi: 10.1111/hiv.12134. Epub 2014 Feb 24.

12.

Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe.

Zoufaly A, Cozzi-Lepri A, Reekie J, Kirk O, Lundgren J, Reiss P, Jevtovic D, Machala L, Zangerle R, Mocroft A, Van Lunzen J; EuroSIDA in EuroCoord.

PLoS One. 2014 Jan 31;9(1):e87160. doi: 10.1371/journal.pone.0087160. eCollection 2014.

13.

High HIV prevalence among children presenting for general consultation in rural Cameroon.

Zoufaly A, Hammerl R, Sunjoh F, Jochum J, Nassimi N, Awasom C, Tayong G, Sauter F, Schmiedel S, van Lunzen J, Burchard G, Feldt T.

Int J STD AIDS. 2014 Sep;25(10):742-4. doi: 10.1177/0956462413518762. Epub 2014 Jan 27.

PMID:
24469969
14.

High levels of PAH-metabolites in urine of e-waste recycling workers from Agbogbloshie, Ghana.

Feldt T, Fobil JN, Wittsiepe J, Wilhelm M, Till H, Zoufaly A, Burchard G, Göen T.

Sci Total Environ. 2014 Jan 1;466-467:369-76. doi: 10.1016/j.scitotenv.2013.06.097. Epub 2013 Aug 7.

PMID:
23921367
15.

Hepatitis E virus infections in HIV-infected patients in Ghana and Cameroon.

Feldt T, Sarfo FS, Zoufaly A, Phillips RO, Burchard G, van Lunzen J, Jochum J, Chadwick D, Awasom C, Claussen L, Drosten C, Drexler JF, Eis-Hübinger AM.

J Clin Virol. 2013 Sep;58(1):18-23. doi: 10.1016/j.jcv.2013.05.004. Epub 2013 Jun 4.

PMID:
23743346
16.

Poor outcome of HIV-infected patients with plasmablastic lymphoma: results from the German AIDS-related lymphoma cohort study.

Schommers P, Wyen C, Hentrich M, Gillor D, Zoufaly A, Jensen B, Bogner JR, Thoden J, Wasmuth JC, Fätkenheuer G, Hoffmann C.

AIDS. 2013 Mar 13;27(5):842-5. doi: 10.1097/QAD.0b013e32835e069d.

PMID:
23574794
17.

Risk factors for development of hemolytic uremic syndrome in a cohort of adult patients with STEC 0104:H4 infection.

Zoufaly A, Cramer JP, Vettorazzi E, Sayk F, Bremer JP, Koop I, de Weerth A, Schmiedel S, Jordan S, Fraedrich K, Asselborn NH, Nitschke M, Neumann-Grutzeck C, Magnus T, Rüther C, Fellermann K, Stahl RK, Wegscheider K, Lohse AW.

PLoS One. 2013;8(3):e59209. doi: 10.1371/journal.pone.0059209. Epub 2013 Mar 22. Erratum in: PLoS One. 2014;9(3):e91617.

18.

Prevalence and determinants of virological failure in HIV-infected children on antiretroviral therapy in rural Cameroon: a cross-sectional study.

Zoufaly A, Fillekes Q, Hammerl R, Nassimi N, Jochum J, Drexler JF, Awasom CN, Sunjoh F, Burchard GD, Burger DM, van Lunzen J, Feldt T.

Antivir Ther. 2013;18(5):681-90. doi: 10.3851/IMP2562. Epub 2013 Mar 18.

PMID:
23502762
19.

Orthotopic liver transplantation in human-immunodeficiency-virus-positive patients in Germany.

Anadol E, Beckebaum S, Radecke K, Paul A, Zoufaly A, Bickel M, Hitzenbichler F, Ganten T, Kittner J, Stoll M, Berg C, Manekeller S, Kalff JC, Sauerbruch T, Rockstroh JK, Spengler U.

AIDS Res Treat. 2012;2012:197501. doi: 10.1155/2012/197501. Epub 2012 Jul 30.

20.

High prevalence of hepatitis B and syphilis co-infections among HIV patients initiating antiretroviral therapy in the north-west region of Cameroon.

Zoufaly A, Onyoh EF, Tih PM, Awasom CN, Feldt T.

Int J STD AIDS. 2012 Jun;23(6):435-8. doi: 10.1258/ijsa.2011.011279.

PMID:
22807539
21.

Late presentation for HIV diagnosis and care in Germany.

Zoufaly A, an der Heiden M, Marcus U, Hoffmann C, Stellbrink H, Voss L, van Lunzen J, Hamouda O; ClinSurv Study Group.

HIV Med. 2012 Mar;13(3):172-81. doi: 10.1111/j.1468-1293.2011.00958.x. Epub 2011 Nov 7.

22.

Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Frank C, Werber D, Cramer JP, Askar M, Faber M, an der Heiden M, Bernard H, Fruth A, Prager R, Spode A, Wadl M, Zoufaly A, Jordan S, Kemper MJ, Follin P, Müller L, King LA, Rosner B, Buchholz U, Stark K, Krause G; HUS Investigation Team.

N Engl J Med. 2011 Nov 10;365(19):1771-80. doi: 10.1056/NEJMoa1106483. Epub 2011 Jun 22.

23.

Clinical outcome of HIV-infected patients with discordant virological and immunological response to antiretroviral therapy.

Zoufaly A, an der Heiden M, Kollan C, Bogner JR, Fätkenheuer G, Wasmuth JC, Stoll M, Hamouda O, van Lunzen J; ClinSurv Study Group.

J Infect Dis. 2011 Feb 1;203(3):364-71. doi: 10.1093/jinfdis/jiq055. Epub 2010 Dec 8.

24.

Cumulative HIV viremia during highly active antiretroviral therapy is a strong predictor of AIDS-related lymphoma.

Zoufaly A, Stellbrink HJ, Heiden MA, Kollan C, Hoffmann C, van Lunzen J, Hamouda O; ClinSurv Study Group.

J Infect Dis. 2009 Jul 1;200(1):79-87. doi: 10.1086/599313.

PMID:
19476437
25.

Aymptomatic CMV viremia is associated with increased levels of serum amyloid A in patients with advanced HIV-infection.

Steininger C, Graninger W, Zoufaly A, Zöllner B, Feucht HH, Kundi M, Stahmer I, Stellbrink HJ, van Lunzen J.

Eur J Med Res. 2008 Jun 24;13(6):304-8.

PMID:
18558558
26.

Intestinal Kaposi's sarcoma may mimic gastrointestinal stromal tumor in HIV infection.

Zoufaly A, Schmiedel S, Lohse A, van Lunzen J.

World J Gastroenterol. 2007 Sep 7;13(33):4514-6.

27.

Emergence of multiple cytomegalovirus strains in blood and lung of lung transplant recipients.

Puchhammer-Stöckl E, Görzer I, Zoufaly A, Jaksch P, Bauer CC, Klepetko W, Popow-Kraupp T.

Transplantation. 2006 Jan 27;81(2):187-94.

PMID:
16436961
28.

Life after death: posttraumatic stress disorder in survivors of cardiac arrest--prevalence, associated factors, and the influence of sedation and analgesia.

Gamper G, Willeit M, Sterz F, Herkner H, Zoufaly A, Hornik K, Havel C, Laggner AN.

Crit Care Med. 2004 Feb;32(2):378-83.

PMID:
14758151

Supplemental Content

Loading ...
Support Center